### Nephrocare Health Services IPO Launch: Key Insights and Overview NephroPlus, operating under Nephrocare Health Services, has launched its Initial Public Offering (IPO) on December 10, 2025. This IPO aims to raise approximately ₹871.05 crores, with a price band set between ₹438 and ₹460 per equity share. The offering includes a fresh issue of shares and an offer for sale, with a retail quota of 35%, Qualified Institutional Buyers (QIB) at 50%, and Non-Institutional Investors (NII) at 15% [https://ipowatch.in/nephrocare-health-ipo-subscription-status]. The IPO will remain open for subscription until December 12, 2025 [https://groww.in/blog/nephrocare-health-services-ipo-day-1]. ### Structure of the Nephrocare Health IPO Overview 1. **IPO Details**: - **Opening and Closing Dates**: The IPO opened on December 10 and will close on December 12, 2025 [https://flattrade.in/kosh/nephrocare-health-services-ipo]. - **Issue Size**: The total issue size is ₹871.05 crores, comprising a fresh issue of ₹353.40 crores and an offer for sale of ₹517.64 crores [https://flattrade.in/kosh/nephrocare-health-services-ipo]. 2. **Price Band and Quotas**: - **Price Band**: The shares are priced between ₹438 and ₹460 [https://mediabrief.com/nephroplus-sets-ipo-price-band-at-₹438-₹460-per-share-opens-december-10]. - **Investor Quotas**: The allocation is divided into 35% for retail investors, 50% for QIBs, and 15% for NIIs [https://ipowatch.in/nephrocare-health-ipo-subscription-status]. 3. **Market Context**: - **Company Background**: NephroPlus is recognized as Asia's largest dialysis service provider, operating 519 clinics globally [https://hybiz.tv/nephroplus-ipo-opens-december-10-asias-largest-dialysis-network]. - **Significance of IPO**: This IPO marks India's 99th mainboard issue of 2025, highlighting the growing interest in healthcare sector investments [https://www.newsbytesapp.com/news/business/nephrocare-ipo-price-band-issue-size-gmp-and-key-dates/story]. ### Supporting Evidence and Data - **Financial Breakdown**: - **Fresh Issue**: ₹353.40 crores from 0.77 crore shares. - **Offer for Sale**: ₹517.64 crores from 1.13 crore shares. - **Subscription Status**: As of Day 1, the subscription status is actively monitored, with updates expected as the offering progresses [https://groww.in/blog/nephrocare-health-services-ipo-day-1]. ### Conclusion and Key Takeaways In summary, the Nephrocare Health Services IPO represents a significant opportunity for investors in the healthcare sector. The following points encapsulate the key findings: 1. **IPO Launch**: The IPO opened on December 10, 2025, and will close on December 12, 2025. 2. **Financial Goals**: Aiming to raise ₹871.05 crores, with a structured price band of ₹438 to ₹460 per share. 3. **Investor Allocation**: The offering is segmented into retail, QIB, and NII quotas, ensuring broad participation. This IPO not only reflects the growing demand for healthcare services but also positions NephroPlus as a key player in the market, potentially attracting significant investor interest [https://www.businesstoday.in/markets/ipo-corner/story/nephroplus-ipo-to-open-on-opens-dec-10-check-price-band-issue-size-other-key-details-504906-2025-12-04].